Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pircher

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Eye (London, England)|February 20, 2018
Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesisH E Killer, A Pircher
Eye (London, England)|November 14, 2015
TLP: a premature conceptA Pircher, H E Killer
Eye (London, England)|April 29, 2017
Relationship between the optic nerve sheath diameter and lumbar cerebrospinal fluid pressure in patients with normal tension glaucomaA Pircher, M Montali, J Berberat, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2014
Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patientA Pircher, C Manzl, M Fiegl, et al.
Free Radical Research|February 29, 2000
Catalase-peroxidases in cyanobacteria--similarities and differences to ascorbate peroxidasesC Obinger, G Regelsberger, P G Furtmüller, et al.
Clinical Neuroradiology|September 16, 2017
Modulation of the Emotional Response to Viewing Strabismic Children in Mothers-Measured by fMRIJ Berberat, M Montali, P Gruber, et al.
Lung Cancer (Amsterdam, Netherlands)|July 22, 2014
Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial)F Kocher, A Pircher, A Mohn-Staudner, et al.
Frontiers in Immunology|October 31, 2022
The liver-resident immune cell repertoire - A boon or a bane during machine perfusion?M Fodor, S Salcher, H Gottschling, et al.
Prostate Cancer and Prostatic Diseases|March 22, 2017
ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter studyI Heidegger, H Klocker, R Pichler, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2014
Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patientsM Fiegl, A Pircher, C Waldthaler, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Eye (London, England)|February 20, 2018
Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesisH E Killer, A Pircher
Eye (London, England)|November 14, 2015
TLP: a premature conceptA Pircher, H E Killer
Eye (London, England)|April 29, 2017
Relationship between the optic nerve sheath diameter and lumbar cerebrospinal fluid pressure in patients with normal tension glaucomaA Pircher, M Montali, J Berberat, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2014
Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patientA Pircher, C Manzl, M Fiegl, et al.
Free Radical Research|February 29, 2000
Catalase-peroxidases in cyanobacteria--similarities and differences to ascorbate peroxidasesC Obinger, G Regelsberger, P G Furtmüller, et al.
Clinical Neuroradiology|September 16, 2017
Modulation of the Emotional Response to Viewing Strabismic Children in Mothers-Measured by fMRIJ Berberat, M Montali, P Gruber, et al.
Lung Cancer (Amsterdam, Netherlands)|July 22, 2014
Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial)F Kocher, A Pircher, A Mohn-Staudner, et al.
Frontiers in Immunology|October 31, 2022
The liver-resident immune cell repertoire - A boon or a bane during machine perfusion?M Fodor, S Salcher, H Gottschling, et al.
Prostate Cancer and Prostatic Diseases|March 22, 2017
ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter studyI Heidegger, H Klocker, R Pichler, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2014
Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patientsM Fiegl, A Pircher, C Waldthaler, et al.
Pageof 2